Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

332 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Rhodes A, et al. Among authors: sprung cl. Intensive Care Med. 2017 Mar;43(3):304-377. doi: 10.1007/s00134-017-4683-6. Epub 2017 Jan 18. Intensive Care Med. 2017. PMID: 28101605 Free article.
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NN, et al. Ziegler EJ, et al. Among authors: sprung cl. N Engl J Med. 1991 Feb 14;324(7):429-36. doi: 10.1056/NEJM199102143240701. N Engl J Med. 1991. PMID: 1988827 Free article. Clinical Trial.
Lung microvascular transport properties measured by multiple indicator dilution methods in patients with adult respiratory distress syndrome. A comparison between patients reversing respiratory failure and those failing to reverse.
Harris TR, Bernard GR, Brigham KL, Higgins SB, Rinaldo JE, Borovetz HS, Sibbald WJ, Kariman K, Sprung CL. Harris TR, et al. Among authors: sprung cl. Am Rev Respir Dis. 1990 Feb;141(2):272-80. doi: 10.1164/ajrccm/141.2.272. Am Rev Respir Dis. 1990. PMID: 2405756
HA-1A in septic patients with ARDS: results from the pivotal trial.
Bigatello LM, Greene RE, Sprung CL, Panacek EA, Straube RC, Zimmerman JL, Maunder RJ, Lanken PN, Pile-Spellmann E, Stanek KS, et al. Bigatello LM, et al. Among authors: sprung cl. Intensive Care Med. 1994 May;20(5):328-34. doi: 10.1007/BF01720904. Intensive Care Med. 1994. PMID: 7930026 Clinical Trial.
An evaluation of the hemodynamic effects of HA-1A human monoclonal antibody.
Kett DH, Quartin AA, Sprung CL, Fisher CJ Jr, Peña MA, Heard SO, Zimmerman JL, Albertson TE, Panacek EA, Eidelman LA, et al. Kett DH, et al. Among authors: sprung cl. Crit Care Med. 1994 Aug;22(8):1227-34. doi: 10.1097/00003246-199408000-00005. Crit Care Med. 1994. PMID: 8045141 Clinical Trial.
New therapeutic approaches in sepsis: a critical review.
Eidelman LA, Pizov R, Sprung CL. Eidelman LA, et al. Among authors: sprung cl. Intensive Care Med. 1995 Nov;21 Suppl 2:S269-72. doi: 10.1007/BF01740766. Intensive Care Med. 1995. PMID: 8636535 Review. No abstract available.
332 results